We use cookies to improve your experience on our Website. We need cookies to continually improve our services, enable certain features, and when we embed third-party services or content, such as the Vimeo video player or Twitter feeds. In such cases, information may also be transferred to third parties. By using our website, you agree to the use of cookies. We use different types of cookies. You can personalize your cookie settings here:

Show detail settings
Please find more information in our privacy statement.

There you may also change your settings later.


Renowned Obesity Researcher Becomes Director of Helmholtz Institute in Leipzig

As of December 1, 2019, Prof. Dr. Matthias Blüher is the director of the Helmholtz Institute for Metabolic, Obesity and Vascular Research (HI-MAG), an institute of the DZD partner Helmholtz Zentrum München in cooperation with the Faculty of Medicine of the University of Leipzig and Leipzig University Hospital. The directorship is a joint position and is connected with the W3 professorship in Clinical Obesity Research at the University of Leipzig.

Prof. Dr. Matthias Blüher. © Christian Tech


Matthias Blüher is one of the leading endocrinologists and diabetologists worldwide in the field of obesity research and its complications. He is speaker of the Collaborative Research Center (SFB) 1052 "Obesity Mechanisms" and senior physician in the Department of Endocrinology and head of the obesity outpatient clinic for adults at Leipzig University Hospital. He has been a member of the board of the German Obesity Society and the European Association for the Study of Diabetes for many years.

Matthias Blüher's research focuses on elucidating the relationships between the function of adipose tissue and the development of diabetes and cardiovascular diseases. He is particularly interested in the role of disturbed body fat distribution and signals from adipose tissue that influence the function of other organs. In clinical research projects, his research group is investigating the interaction between biological factors and environmental influences that lead to a pathological increase in body weight.

The aim of HI-MAG's research is to uncover the molecular basis of adipose tissue dysfunction, metabolic processes and vascular alterations in order to develop more effective therapies for obesity and its complications through a clinical translational research approach.